Figure 2
From: An exploratory investigation of the influence of publication on translational medicine research
The managed translational pathway. This is the managed translational pathway between the MRC and NIHR. The overlap between the stages is deliberate - it is quite possible that some studies or trials could be funded by more than one body; this overlap is deliberate to ensure that studies do not fall between gaps. Successful publication and a managed pathway should led to faster translation through this pathway, which currently van take at least 15 years from discovery to changes in clinical practice.